Abstract
Since its discovery, the naturally occurring RNA (ribonucleic acid)
interference effect has been acclaimed as the most exciting technical
breakthrough in biological research in the last decade. Some industry analysts
predict that RNA interference (RNAi) may even surpass PCR as a top technology.
RNAi allows scientists to silence the expression or effect of a gene under
study. This is known as gene knockdown. This field has rapidly emerged as a
fast-growing new market. The purpose of this TriMark Publications report is to
review the market for RNAi testing equipment and supplies. RNAi is a mechanism
in molecular biology where the presence of certain fragments of
double-stranded RNA (dsRNA) interferes with the expression of a particular
gene which shares a similar sequence with the dsRNA.
This study defines the dollar volume of sales, both worldwide and in the U.S.,
and analyzes the factors that influence market size and growth for RNAi
testing. The main objectives of this study are to: 1) understand the different
sectors of RNAi testing market and to look at a description of the
instruments, reagents and supplies marketed by major companies in each
segment; 2) obtain a complete understanding of the individual RNAi-testing
platforms-from basic principles to clinical applications; 3) discover feasible
market opportunities by identifying high-growth applications in different
analytical diagnostic areas, with a focus on the biggest and expanding
markets; 4) focus on global industry developments and trends through an
in-depth analysis of the major world markets for RNAi measurement technology,
including growth forecasts; and 5) present market figures related to the
current value of RNAi testing, market projections, market share, key players
and sector growth rates.
|